A tragic stampede at New Delhi Railway Station has resulted in the death of 18 individuals following a crowd surge of passengers heading to Maha Kumbh. Victims' belongings were scattered across ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other cheap high dividend stocks. According to Deutsche Bank Wealth Management, the global ...

At least 15 people were killed in a stampede at a railway station in India's capital of New Delhi, an official said Sunday.Delhi's caretaker chief minister Atishi, who uses only one name ...

At least 18 people have died, including 14 women, after a stampede at the main train station in New Delhi, according to local media. The deadly surge happened at about 8pm local time on Saturday ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.

At least 18 people, including five children, were killed and over a dozen were injured in a stampede at New Delhi Railway Station on Saturday night, which was caused by a sudden surge of ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

A crush at New Delhi Railway Station has left around 18 people dead and at least 10 injured. Thousands of people reportedly crammed into the railway station on Saturday night as they tried to ...

Ajay has worked in tech journalism for over a decade as a reporter, analyst, product reviewer, and editor. He got his start in consumer tech, breaking Android news at Newsweek before going to ...